C139H153F9N32O6S — CID 161323110
N-[3-(azetidin-1-ylmethyl)-5-tert-butylphenyl]-3-[4-(1,5-dimethylpyrazol-4-yl)triazol-1-yl]-4-methylbenzamide;N-[3-tert-butyl-5-(pyrrolidin-1-ylmethyl)phenyl]-3-[4-(1,5-dimethylpyrazol-4-yl)triazol-1-yl]-4-methylbenzamide;N-[3-butyl-5-(trifluoromethyl)phenyl]-3-[4-(1,5-dimethylpyrazol-4-yl)triazol-1-yl]-4-methylbenzamide;3-[4-(5-methoxy-3-pyridinyl)triazol-1-yl]-4-methyl-N-[3-(3-methylbutyl)-5-(trifluoromethyl)phenyl]benzamide;4-methyl-3-[4-[2-(methylamino)-1,3-thiazol-5-yl]triazol-1-yl]-N-[3-(pyrrolidin-1-ylmethyl)-5-(trifluoromethyl)phenyl]benzamide (PubChem CID 161323110) has the molecular formula C139H153F9N32O6S and a molecular weight of 2571.02 g/mol. Its IUPAC name is N-[3-(azetidin-1-ylmethyl)-5-tert-butylphenyl]-3-[4-(1,5-dimethylpyrazol-4-yl)triazol-1-yl]-4-methylbenzamide;N-[3-tert-butyl-5-(pyrrolidin-1-ylmethyl)phenyl]-3-[4-(1,5-dimethylpyrazol-4-yl)triazol-1-yl]-4-methylbenzamide;N-[3-butyl-5-(trifluoromethyl)phenyl]-3-[4-(1,5-dimethylpyrazol-4-yl)triazol-1-yl]-4-methylbenzamide;3-[4-(5-methoxy-3-pyridinyl)triazol-1-yl]-4-methyl-N-[3-(3-methylbutyl)-5-(trifluoromethyl)phenyl]benzamide;4-methyl-3-[4-[2-(methylamino)-1,3-thiazol-5-yl]triazol-1-yl]-N-[3-(pyrrolidin-1-ylmethyl)-5-(trifluoromethyl)phenyl]benzamide.
| Compound Name | N-[3-(azetidin-1-ylmethyl)-5-tert-butylphenyl]-3-[4-(1,5-dimethylpyrazol-4-yl)triazol-1-yl]-4-methylbenzamide;N-[3-tert-butyl-5-(pyrrolidin-1-ylmethyl)phenyl]-3-[4-(1,5-dimethylpyrazol-4-yl)triazol-1-yl]-4-methylbenzamide;N-[3-butyl-5-(trifluoromethyl)phenyl]-3-[4-(1,5-dimethylpyrazol-4-yl)triazol-1-yl]-4-methylbenzamide;3-[4-(5-methoxy-3-pyridinyl)triazol-1-yl]-4-methyl-N-[3-(3-methylbutyl)-5-(trifluoromethyl)phenyl]benzamide;4-methyl-3-[4-[2-(methylamino)-1,3-thiazol-5-yl]triazol-1-yl]-N-[3-(pyrrolidin-1-ylmethyl)-5-(trifluoromethyl)phenyl]benzamide |
|---|---|
| PubChem CID | 161323110 |
| Molecular Formula | C139H153F9N32O6S |
| Molecular Weight | 2571.02 g/mol |
| Exact Mass | 2569.22 |
| IUPAC Name | N-[3-(azetidin-1-ylmethyl)-5-tert-butylphenyl]-3-[4-(1,5-dimethylpyrazol-4-yl)triazol-1-yl]-4-methylbenzamide;N-[3-tert-butyl-5-(pyrrolidin-1-ylmethyl)phenyl]-3-[4-(1,5-dimethylpyrazol-4-yl)triazol-1-yl]-4-methylbenzamide;N-[3-butyl-5-(trifluoromethyl)phenyl]-3-[4-(1,5-dimethylpyrazol-4-yl)triazol-1-yl]-4-methylbenzamide;3-[4-(5-methoxy-3-pyridinyl)triazol-1-yl]-4-methyl-N-[3-(3-methylbutyl)-5-(trifluoromethyl)phenyl]benzamide;4-methyl-3-[4-[2-(methylamino)-1,3-thiazol-5-yl]triazol-1-yl]-N-[3-(pyrrolidin-1-ylmethyl)-5-(trifluoromethyl)phenyl]benzamide |
| SMILES | CCCCc1cc(NC(=O)c2ccc(C)c(-n3cc(-c4cnn(C)c4C)nn3)c2)cc(C(F)(F)F)c1.CNc1ncc(-c2cn(-c3cc(C(=O)Nc4cc(CN5CCCC5)cc(C(F)(F)F)c4)ccc3C)nn2)s1.COc1cncc(-c2cn(-c3cc(C(=O)Nc4cc(CCC(C)C)cc(C(F)(F)F)c4)ccc3C)nn2)c1.Cc1ccc(C(=O)Nc2cc(CN3CCC3)cc(C(C)(C)C)c2)cc1-n1cc(-c2cnn(C)c2C)nn1.Cc1ccc(C(=O)Nc2cc(CN3CCCC3)cc(C(C)(C)C)c2)cc1-n1cc(-c2cnn(C)c2C)nn1 |
| InChI | InChI=1S/C30H37N7O.C29H35N7O.C28H28F3N5O2.C26H26F3N7OS.C26H27F3N6O/c1-20-9-10-23(15-28(20)37-19-27(33-34-37)26-17-31-35(6)21(26)2)29(38)32-25-14-22(18-36-11-7-8-12-36)13-24(16-25)30(3,4)5;1-19-8-9-22(14-27(19)36-18-26(32-33-36)25-16-30-34(6)20(25)2)28(37)31-24-13-21(17-35-10-7-11-35)12-23(15-24)29(3,4)5;1-17(2)5-7-19-9-22(28(29,30)31)13-23(10-19)33-27(37)20-8-6-18(3)26(12-20)36-16-25(34-35-36)21-11-24(38-4)15-32-14-21;1-16-5-6-18(11-22(16)36-15-21(33-34-36)23-13-31-25(30-2)38-23)24(37)32-20-10-17(14-35-7-3-4-8-35)9-19(12-20)26(27,28)29;1-5-6-7-18-10-20(26(27,28)29)13-21(11-18)31-25(36)19-9-8-16(2)24(12-19)35-15-23(32-33-35)22-14-30-34(4)17(22)3/h9-10,13-17,19H,7-8,11-12,18H2,1-6H3,(H,32,38);8-9,12-16,18H,7,10-11,17H2,1-6H3,(H,31,37);6,8-17H,5,7H2,1-4H3,(H,33,37);5-6,9-13,15H,3-4,7-8,14H2,1-2H3,(H,30,31)(H,32,37);8-15H,5-7H2,1-4H3,(H,31,36) |
| InChIKey | VKKFPXCPLIKUAY-UHFFFAOYSA-N |
| XLogP | 28.48 |
| TPSA | 409.27 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 34 |
| Rotatable Bonds | 34 |
| Heavy Atoms | 187 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2571.02 |
| LogP ≤ 5 | 28.48 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 34 |